Cargando…

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics

Synthetic peptidomimetics may be designed to mimic functions of antimicrobial peptides, including potentiation of antibiotics, yet possessing improved pharmacological properties. Pairwise screening of 42 synthetic peptidomimetics combined with the antibiotics azithromycin and rifampicin in multidrug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Kristin R., Jana, Bimal, Hansen, Anna Mette, Nielsen, Hanne Mørck, Franzyk, Henrik, Guardabassi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615261/ https://www.ncbi.nlm.nih.gov/pubmed/31334131 http://dx.doi.org/10.3389/fcimb.2019.00236

Ejemplares similares

Macrolide Resistance and In Vitro Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli
por: Ma, Yibing, et al.
Publicado: (2022)

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
por: Molchanova, Natalia, et al.
Publicado: (2017)

The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph(12−38) With Antibiotics Azithromycin and Rifampicin Enhances Bactericidal Activity Against Pseudomonas Aeruginosa
por: Liu, Jie, et al.
Publicado: (2020)

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
por: Molchanova, Natalia, et al.
Publicado: (2019)

Targeting malaria parasites with novel derivatives of azithromycin
por: Burns, Amy L., et al.
Publicado: (2022)

Heme Uptake and Utilization by Gram-Negative Bacterial Pathogens
por: Richard, Kaylie L., et al.
Publicado: (2019)

Differential Gene Sets Profiling in Gram-Negative and Gram-Positive Sepsis
por: Wang, Qingliang, et al.
Publicado: (2022)

Drug Discovery and Repurposing Inhibits a Major Gut Pathogen-Derived Oncogenic Toxin
por: Metz, Paul, et al.
Publicado: (2019)

Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
por: Bhandari, Vasundhra, et al.
Publicado: (2018)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Models of Hfq interactions with small non-coding RNA in Gram-negative and Gram-positive bacteria
por: Watkins, Derrick, et al.
Publicado: (2023)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
por: Peyclit, Lucie, et al.
Publicado: (2019)

Adaptive Evolution of Escherichia coli to an α-Peptide/β-Peptoid Peptidomimetic Induces Stable Resistance
por: Hein-Kristensen, Line, et al.
Publicado: (2013)

Editorial: Quorum-sensing in Gram-positive pathogens – mechanisms, role in infection, and potential as a therapeutic target
por: Otto, Michael, et al.
Publicado: (2023)

The survival analysis of rifampicin/multidrug-resistant tuberculosis patients based on the levels of inflammatory biomarkers: a retrospective cohort study
por: Yu, Qi, et al.
Publicado: (2023)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
por: Shirley, Debbie-Ann, et al.
Publicado: (2021)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

Characterization of resistance genes and plasmids from sick children caused by Salmonella enterica resistance to azithromycin in Shenzhen, China
por: Wang, Hongmei, et al.
Publicado: (2023)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Panomics to decode virulence and fitness in Gram-negative bacteria
por: Singh, Anuradha, et al.
Publicado: (2022)

Repurposing the Antiemetic Metoclopramide as an Antiviral Against Dengue Virus Infection in Neuronal Cells
por: Shen, Ting-Jing, et al.
Publicado: (2021)

Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)

Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
por: Ajmal, Amar, et al.
Publicado: (2023)

In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2018)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
por: Cheng, Yu-Shan, et al.
Publicado: (2019)

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
por: Boyd, Natalie K., et al.
Publicado: (2021)

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
por: Gu, Yuzhen, et al.
Publicado: (2023)

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors
por: Radosevic, Draginja, et al.
Publicado: (2019)

An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli
por: Khuntayaporn, Piyatip, et al.
Publicado: (2022)

Editorial: Multidrug gram-negative bacilli : current situation and future perspective
por: López-Jácome, Luis Esaú, et al.
Publicado: (2023)

Repurposing Azithromycin for Neonatal Neuroprotection
por: Barks, John D.E., et al.
Publicado: (2019)

Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
por: Amemiya, Kei, et al.
Publicado: (2021)

Repurposing Carvedilol as a Novel Inhibitor of the Trypanosoma cruzi Autophagy Flux That Affects Parasite Replication and Survival
por: Rivero, Cynthia Vanesa, et al.
Publicado: (2021)

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
por: Breine, Anke, et al.
Publicado: (2022)

Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans
por: Lin, Jiaying, et al.
Publicado: (2022)

Application of TonB-Dependent Transporters in Vaccine Development of Gram-Negative Bacteria
por: Wang, Jia, et al.
Publicado: (2021)

Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms
por: Zhu, Xiaoli, et al.
Publicado: (2022)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria, volume II
por: Daoud, Ziad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s1dqs26p5mtq3nelu288pmb7fi